4 Household Name Stocks With Dividends in Danger
Four household names are dangling yields above 5% at a moment when their earnings, cash flow, and debt levels raise serious questions about whether those payouts can last. Retirees counting on that…
Four household names are dangling yields above 5% at a moment when their earnings, cash flow, and debt levels raise serious questions about whether those payouts can last. Retirees counting on that…
When the paycheck stops at retirement, your portfolio has to carry the weight, and one dividend cut can force painful choices between a tighter budget and selling shares at the worst moment.…
Pfizer's yield towers over Johnson and Johnson's, but a bigger number on paper can hide serious risks underneath. Before you chase that payout, consider what a frozen dividend, rising debt, and a…
Johnson & Johnson just logged its 64th straight year of dividend growth, but biosimilar threats, a MedTech slowdown, and lingering talc litigation raise a real question about whether that streak justifies buying…
Some of the most recognizable dividend stocks in the market have been paying shareholders with money they do not actually earn, and the accounting trail reveals exactly how far six of them…
Moderna stock has turned a handful of patient shareholders into believers, but a gain this size forces a choice that most investors never plan for in advance. The pipeline promise is real,…
A plague headline out of Siberia lifted vaccine stocks, and the agencies closest to the case have since described the risk as low. That reversal in sentiment lands hardest on Novavax (NASDAQ:NVAX),…
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are trading as though the company’s messenger RNA (mRNA) cancer vaccine has already cleared its final test, even though the complete Phase 3 dataset…
Ten consecutive earnings beats and a shrinking COVID hangover have Wall Street split on whether Pfizer deserves a breakout or a ceiling, and the answer hinges on a single pipeline deal that…
Three struggling companies keep sending dividend checks while investors wait for their repairs to kick in, but only one of them has a yield that cash flow actually supports without a fight.
Turning a monthly paycheck into permanent investment income sounds straightforward until you realize how dramatically the required capital swings based on one variable most people overlook when building their retirement portfolio.
Buyers are stepping into Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares, evidently. The move comes one session after a Citigroup (NYSE:C) downgrade to Sell, a sign the market still prizes the company’s…
A fat dividend yield can mean a generous payout or a stock the market has already written off, and right now six familiar names are flashing signals that suggest the difference matters…
A 5% Treasury yield raises the bar for every dividend stock in a retirement portfolio, but four large-cap payers in real estate, telecom, tobacco, and healthcare are generating the cash flow to…
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is drawing attention Wednesday after Citigroup downgraded the biotech company to Sell from Hold, arguing that the recent rally has pushed the valuation well ahead…